Incidence of agranulocytosis in Southwest France.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 15330129)

Published in Eur J Epidemiol on January 01, 2004

Authors

Hélène Théophile1, Bernard Bégaud, Karin Martin, Juan Ramon Laporte, Dolores Capella

Author Affiliations

1: Department de Pharmacologie, EA 3676, IFR 99, Université Victor Segalen, CHU Pellegrin, Bordeaux Cedex, France.

Articles cited by this

A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med (1999) 3.11

Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry (1996) 2.51

Neutropenia and agranulocytosis in England and Wales: incidence and risk factors. Am J Hematol (2003) 1.48

Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl (1996) 1.04

Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature. Clin Lab Haematol (2002) 1.00

Descriptive epidemiology of agranulocytosis. Arch Intern Med (1992) 0.97

Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study. Clin Pharmacol Ther (1991) 0.93

Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use. J Clin Epidemiol (1998) 0.88

Incidence and cause of aplastic anemia, hemolytic anemia, agranulocytosis and thrombocytopenia. Acta Med Scand (1981) 0.85

Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg (1999) 0.84

[Acute drug-induced agranulocytosis: experience of the Regional Center of Pharmacovigilance of Lyon over 7 years]. Therapie (1997) 0.80

European network for the case-population surveillance of rare diseases (Euronet). A prospective feasibility study. Eur J Clin Pharmacol (1998) 0.80

[Incidence and probable etiology of toxic agranulocytosis in a definite population in the province of Buenos Aires (1963-1976)]. Medicina (B Aires) (1994) 0.79

Drug-associated agranulocytosis: experience at Strasbourg Teaching Hospital. Arch Intern Med (1999) 0.79

Articles by these authors

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study. Cardiovasc Drugs Ther (2005) 5.41

Benzodiazepine use and risk of dementia: prospective population based study. BMJ (2012) 4.32

Intimate bacterial-fungal interaction triggers biosynthesis of archetypal polyketides in Aspergillus nidulans. Proc Natl Acad Sci U S A (2009) 2.86

Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation. J Am Soc Nephrol (2009) 1.72

Elizabethkingia anophelis sp. nov., isolated from the midgut of the mosquito Anopheles gambiae. Int J Syst Evol Microbiol (2010) 1.68

Differences between clinical trials and postmarketing use. Br J Clin Pharmacol (2004) 1.54

Pharmaco-epidemiology: what do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions? Br J Psychiatry (2004) 1.49

Rates of spontaneous reporting of adverse drug reactions in France. JAMA (2002) 1.45

Patterns and correlates of benzodiazepine use in the French general population. Eur J Clin Pharmacol (2004) 1.39

Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Saf (2010) 1.38

Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol (2005) 1.33

Benzodiazepine use and risk of dementia: a nested case-control study. J Clin Epidemiol (2002) 1.15

Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions. Br J Clin Pharmacol (2007) 1.10

Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Drug Saf (2005) 1.06

Adolescents' experiences of childbirth: contrasts with adults. J Midwifery Womens Health (2003) 1.06

Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance. IEEE Trans Inf Technol Biomed (2005) 1.06

Segmented flow generation by chip reactors for highly parallelized cell cultivation. Biosens Bioelectron (2004) 1.04

Psychotropic drugs use and risk of heat-related hospitalisation. Eur Psychiatry (2007) 1.02

Complete genome sequence of the filamentous gliding predatory bacterium Herpetosiphon aurantiacus type strain (114-95(T)). Stand Genomic Sci (2011) 0.99

Is there really a link between benzodiazepine use and the risk of dementia? Expert Opin Drug Saf (2015) 0.99

A simple method to estimate sample sizes for safety equivalence studies using inverse sampling. J Clin Epidemiol (2003) 0.96

Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice. BMC Complement Altern Med (2012) 0.96

[Medical and socio-economical impact of drug-induced adverse reactions]. Presse Med (2005) 0.95

Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death. Drug Saf (2005) 0.95

Revision of the genus Massilia La Scola et al. 2000, with an emended description of the genus and inclusion of all species of the genus Naxibacter as new combinations, and proposal of Massilia consociata sp. nov. Int J Syst Evol Microbiol (2010) 0.94

Improving pharmacovigilance in Europe. BMJ (2010) 0.94

The risk of cognitive impairment in older community-dwelling women after benzodiazepine use. Age Ageing (2008) 0.93

A new method for assessing drug causation provided agreement with experts' judgment. J Clin Epidemiol (2006) 0.91

Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study. BMC Cardiovasc Disord (2011) 0.91

Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study. Drug Saf (2012) 0.90

Does age increase the risk of adverse drug reactions? Br J Clin Pharmacol (2002) 0.89

Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference. Drug Saf (2013) 0.88

Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre. Drug Saf (2010) 0.87

Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France. Drug Saf (2012) 0.87

Concordance between prescriber- and patient-reported previous medical history and NSAID indication in the CADEUS cohort. Pharmacoepidemiol Drug Saf (2010) 0.87

Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital. Intensive Care Med (2007) 0.87

Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database. Pharmacoepidemiol Drug Saf (2004) 0.87

A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France. Drug Saf (2013) 0.87

How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database. Eur J Clin Pharmacol (2010) 0.86

Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study. Neuroepidemiology (2002) 0.86

Devosia epidermidihirudinis sp. nov. isolated from the surface of a medical leech. Antonie Van Leeuwenhoek (2013) 0.86

Resuscitation-promoting factors: distribution among actinobacteria, synthesis during life-cycle and biological activity. Antonie Van Leeuwenhoek (2006) 0.85

Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care. Schizophr Res (2005) 0.85

An updated method improved the assessment of adverse drug reaction in routine pharmacovigilance. J Clin Epidemiol (2012) 0.85

Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases. Pharmacoepidemiol Drug Saf (2013) 0.84

Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting. Stat Med (2009) 0.84

Duganella phyllosphaerae sp. nov., isolated from the leaf surface of Trifolium repens and proposal to reclassify Duganella violaceinigra into a novel genus as Pseudoduganella violceinigra gen. nov., comb. nov. Syst Appl Microbiol (2011) 0.83

[Results from the observational study EPIGRAM: management of excess weight in general practice and follow-up of patients treated with orlistat]. Therapie (2005) 0.82

Impact of prescriber nonresponse on patient representativeness. Epidemiology (2008) 0.82

Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France. Pharmacoepidemiol Drug Saf (2012) 0.82

A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding. Br J Clin Pharmacol (2008) 0.82

Niabella hirudinis and Niabella drilacis sp. nov., isolated from the medicinal leech Hirudo verbana. Int J Syst Evol Microbiol (2013) 0.81

Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system. Drug Saf (2011) 0.81

Alicyclobacillus consociatus sp. nov., isolated from a human clinical specimen. Int J Syst Evol Microbiol (2013) 0.81

The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers. Br J Clin Pharmacol (2009) 0.81

Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model. Fundam Clin Pharmacol (2004) 0.80

Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France. BMC Musculoskelet Disord (2011) 0.80

Real-time image processing for label-free enrichment of Actinobacteria cultivated in picolitre droplets. Lab Chip (2013) 0.80

NSAID use profiles derived from reimbursement data in France. Therapie (2005) 0.79

[Treatment of erectile dysfunction by phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NOIAN)]. Prog Urol (2007) 0.79

Massilia oculi sp. nov., isolated from a human clinical specimen. Int J Syst Evol Microbiol (2011) 0.79

Use of health insurance claim patterns to identify patients using nonsteroidal anti-inflammatory drugs for rheumatoid arthritis. Pharmacoepidemiol Drug Saf (2012) 0.78

Influence of the drug exposure definition on the assessment of the antipsychotic metabolic impact in patients initially treated with mood-stabilizers. Br J Clin Pharmacol (2012) 0.78

Medicines submitted to narcotics regulations in France, 1992-2007. Fundam Clin Pharmacol (2009) 0.78

Relevance of a "Dear Doctor letter" to alert healthcare providers to new recommendations for vitamin D administration. Eur J Clin Pharmacol (2011) 0.77

Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users. Br J Clin Pharmacol (2010) 0.77

Are traditional NSAIDs prescribed appropriately among French elderly with osteoarthritis? Results from the CADEUS cohort. Eur J Clin Pharmacol (2011) 0.77

Risk of death related to psychotropic drug use in older people during the European 2003 heatwave: a population-based case-control study. Am J Geriatr Psychiatry (2009) 0.77

Less use of NSAIDs in long-term than in recent chondroitin sulphate users in osteoarthritis: a pharmacy-based observational study in France. Therapie (2006) 0.77

The case-population study design: an analysis of its application in pharmacovigilance. Drug Saf (2011) 0.77

Genomics-guided discovery of endophenazines from Kitasatospora sp. HKI 714. J Nat Prod (2014) 0.77

[Celecoxib prescription: data from the "Sécurité Sociale" database of the Aquitaine Region, South-Western, France]. Therapie (2005) 0.76

Pharmacoepidemiology of psychotropic drugs: examples of current research challenges on major public health issues. Epidemiol Psichiatr Soc (2009) 0.76

Benzodiazepine utilization patterns in Alzheimer's disease patients. Pharmacoepidemiol Drug Saf (2003) 0.76

Effects of armagnac or vodka on platelet aggregation in healthy volunteers: a randomized controlled clinical trial. Thromb Res (2005) 0.76

Paenibacillus chartarius sp. nov., isolated from a paper mill. Int J Syst Evol Microbiol (2011) 0.76

Jhaorihella thermophila gen. nov., sp. nov., a moderately thermophilic bacterium isolated from a coastal hot spring. Int J Syst Evol Microbiol (2010) 0.75

Citricoccus parietis sp. nov., isolated from a mould-colonized wall and emended description of Citricoccus alkalitolerans Li et al. 2005. Int J Syst Evol Microbiol (2009) 0.75

Castellaniella hirudinis sp. nov., isolated from the skin of Hirudo verbana. Int J Syst Evol Microbiol (2012) 0.75

[Some questions about statins]. Therapie (2003) 0.75

[Pharmacoepidemiology of psychotropic medication: utilisation and impact in real-life conditions]. Therapie (2006) 0.75

[Methodology and quality control in EPIGRAM, a pharmacoepidemiological study of obesity in general practice]. Therapie (2005) 0.75

Nocardia grenadensis sp. nov., isolated from sand of the Caribbean Sea. Int J Syst Evol Microbiol (2011) 0.75

Prauserella muralis sp. nov., from the indoor environment. Int J Syst Evol Microbiol (2009) 0.75

Novosphingobium fuchskuhlense sp. nov., isolated from the north-east basin of Lake Grosse Fuchskuhle. Int J Syst Evol Microbiol (2012) 0.75

[Antidepressant adverse effects in the elderly: analysis of spontaneous reports in France]. Therapie (2005) 0.75

Lysinibacillus contaminans sp. nov., isolated from surface water. Int J Syst Evol Microbiol (2013) 0.75

Luteolibacter cuticulihirudinis sp. nov., isolated from Hirudo medicinalis. Antonie Van Leeuwenhoek (2012) 0.75

Application of micro-segmented flow for two-dimensional characterization of the combinatorial effect of zinc and copper ions on metal-tolerant Streptomyces strains. Appl Microbiol Biotechnol (2013) 0.75

Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect? Eur J Clin Pharmacol (2011) 0.75

Kaistia hirudinis sp. nov., isolated from the skin of Hirudo verbana. Int J Syst Evol Microbiol (2013) 0.75

Comparison of patient questionnaires and plasma assays in intentional drug overdoses. Basic Clin Pharmacol Toxicol (2004) 0.75

The delusion of reducing sample size. Eur J Clin Pharmacol (2003) 0.75

Emended description of Actinoplanes friuliensis and description of Actinoplanes nipponensis sp. nov., antibiotic-producing species of the genus Actinoplanes. Int J Syst Evol Microbiol (2013) 0.75

Potential impact of oral contraceptive choice on myocardial infarction mortality and deep vein thrombosis. J Fam Plann Reprod Health Care (2005) 0.75

Synergistic effects of metal nanoparticles and a phenolic uncoupler using microdroplet-based two-dimensional approach. J Environ Monit (2010) 0.75

Micromonospora schwarzwaldensis sp. nov., a producer of telomycin, isolated from soil. Int J Syst Evol Microbiol (2013) 0.75